These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26301121)

  • 1. Designer probiotics: Development and applications in gastrointestinal health.
    Sleator RD
    World J Gastrointest Pathophysiol; 2015 Aug; 6(3):73-8. PubMed ID: 26301121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003.
    Sheehan VM; Sleator RD; Hill C; Fitzgerald GF
    Microbiology (Reading); 2007 Oct; 153(Pt 10):3563-3571. PubMed ID: 17906153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patho-biotechnology; using bad bugs to make good bugs better.
    Sleator RD; Hill C
    Sci Prog; 2007; 90(Pt 1):1-14. PubMed ID: 17455762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered pharmabiotics with improved therapeutic potential.
    Sleator RD; Hill C
    Hum Vaccin; 2008; 4(4):271-4. PubMed ID: 18682694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Bioengineered Bugs' - a patho-biotechnology approach to probiotic research and applications.
    Sleator RD; Hill C
    Med Hypotheses; 2008; 70(1):167-9. PubMed ID: 17452084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response.
    Corr SC; Gahan CG; Hill C
    FEMS Immunol Med Microbiol; 2007 Aug; 50(3):380-8. PubMed ID: 17537177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics -- a viable therapeutic alternative for enteric infections especially in the developing world.
    Sleator RD
    Discov Med; 2010 Aug; 10(51):119-24. PubMed ID: 20807472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of probiotics, included in peanut butter, on the fate of selected Salmonella and Listeria strains under simulated gastrointestinal conditions.
    Klu YA; Chen J
    J Appl Microbiol; 2016 Apr; 120(4):1052-60. PubMed ID: 26836043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118.
    Sheehan VM; Sleator RD; Fitzgerald GF; Hill C
    Appl Environ Microbiol; 2006 Mar; 72(3):2170-7. PubMed ID: 16517668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics to enhance anti-infective defences in the gastrointestinal tract.
    Gill HS
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):755-73. PubMed ID: 14507586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro probiotic characteristics of Lactobacillus plantarum ZDY 2013 and its modulatory effect on gut microbiota of mice.
    Huang R; Tao X; Wan C; Li S; Xu H; Xu F; Shah NP; Wei H
    J Dairy Sci; 2015 Sep; 98(9):5850-61. PubMed ID: 26142853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology and probiotic impact of the newborn and young children intestinal microflora.
    Bezirtzoglou E; Stavropoulou E
    Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the relationship between exposure to technological and gastrointestinal stress and probiotic functional properties of lactobacilli and bifidobacteria.
    Amund OD
    Can J Microbiol; 2016 Sep; 62(9):715-25. PubMed ID: 27461506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.
    Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK
    Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viability, Acid and Bile Tolerance of Spray Dried Probiotic Bacteria and Some Commercial Probiotic Supplement Products Kept at Room Temperature.
    Dianawati D; Mishra V; Shah NP
    J Food Sci; 2016 Jun; 81(6):M1472-9. PubMed ID: 27145163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp.
    Kailasapathy K; Chin J
    Immunol Cell Biol; 2000 Feb; 78(1):80-8. PubMed ID: 10651933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract.
    Watson D; Sleator RD; Hill C; Gahan CG
    BMC Microbiol; 2008 Oct; 8():176. PubMed ID: 18844989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
    Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
    J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains.
    Schoster A; Kokotovic B; Permin A; Pedersen PD; Dal Bello F; Guardabassi L
    Anaerobe; 2013 Apr; 20():36-41. PubMed ID: 23471038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The probiotic paradox: live and dead cells are biological response modifiers.
    Adams CA
    Nutr Res Rev; 2010 Jun; 23(1):37-46. PubMed ID: 20403231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.